Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00037804 · ClinicalTrials.gov registry record · Phase 1
Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00037804: Completed Phase 1 study, sponsored by Pfizer.
NCT00037804 is a Phase 1 study that has completed, run by Pfizer. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00037804, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
Drugs used in chemotherapy us different ways to stop tumor cells from dividing so they stop growing or die. Irinotecan may be effective in treating patients with refractory solid tumors and liver dysfunction.
Interventions
- DRUG Irinotecan
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
What the finished NCT00037804 record still lists
NCT00037804 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Irinotecan is the first listed.
NCT00037804 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00037804 about?
NCT00037804 is a clinical study titled "Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction". Drugs used in chemotherapy us different ways to stop tumor cells from dividing so they stop growing or die. Irinotecan may be effective in treating patients with refractory solid tumors and liver dysfunction.
What is the current status of trial NCT00037804?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00037804?
The interventions under investigation include: Irinotecan (DRUG).
Who is sponsoring clinical trial NCT00037804?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.